More results...
President repeats threat to bring in levies ‘within next week or so’ in attempt to get companies to move production to USShares in European pharmaceutical companies have sunk to a four-month low, after Donald Trump repeated his threats to introduce tar…
Pascal Soriot refuses to be drawn, however, on reports AZ could move its main stock market listing across the AtlanticAstraZeneca’s chief executive has hailed the “vital importance of the US” to the British drugmaker, days after announcing a $50bn (£37…
UK company to fund new drug manufacturing facility in Virginia and expand R&D facilities around USBusiness live – latest updatesAstraZeneca has announced it will invest $50bn (£37bn) in the US by 2030, the latest in a string of pledges by pharmaceu…
UK and rest of Europe risk losing out to US and China unless they ramp up spending on new medicines, says CEO Pascal SoriotBusiness live – latest updatesAstraZeneca said it was shifting the production of some medicines sold in the US from Europe to the…
The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this yearAstraZeneca is used to facing protests over pay at its annual general meetings, given the position of its chief executive, Pascal Soriot, …
Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansionBusiness live – latest updatesAstraZeneca will invest $2.5bn (£1.9bn) in research and manufacturing in Beijing, as the pharmaceutical company tries t…
UK pharma group acquires Belgium’s EsoBiotec as it announces EU has approved Imfinzi lung cancer drugBusiness live – latest updatesAstraZeneca has struck a $1bn (£773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies, t…
UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pillAstraZeneca is making a big push into the weight-loss drug market, striking an exclusive licence agreement with a Chinese company for an obesity and type 2…
CEOs received average increase of 16% while pay of many working for them failed to keep up with inflationThe bosses of the UK’s 100 biggest listed companies collected an average £500,000 pay rise last year, while many of the millions of people working …
UK’s largest stock-market-listed firm weighs up Hong Kong or Shanghai listing to shield it from geopolitical tensionsBusiness live – latest updatesAstraZeneca is considering spinning off its business in China and listing it in Hong Kong or Shanghai to …